BioSpace News Archive

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today announced that Brian Schwartz, MD, who served for twelve years as Chief Medical Officer of ArQule, Inc. and led ArQule’s research and development programs through its $2.7 billion acquisition by Merck earlier this year, joined the Enlivex Board of Directors on November, 15, 2020.

Global Superstar Featured in New Public Service Campaign Revealing How Advice from Her Mother Prior to Her Tragic Passing from Pancreatic Cancer Is Giving Her Inspiration to Advocate for Others

Alpha Data’s latest ADM-PA100 board featuring the Xilinx Adaptive Compute Acceleration Platform

Seasoned Oncology Executive Brings Voice of Cancer Centers to Further Precision Patient-Matching and Help Accelerate Clinical Trial Program Success

Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD , and Michael Milone, MD, Ph.D ., as recipients of an Agilent Thought Leader Award. Both scientists are being recognized for their joint contributions to the field of CAR T-cell mediated cancer immunot

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Larry A. Pickett, Jr. as Chief Information & Digital Officer.

Six of the most well-known, respected, and long-established orthopedic group practices in Texas have announced their launch as OrthoLoneStar, a single combined group practice in 2021.

Sapience Therapeutics, Inc., a clinical stage biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it has raised $14 million in its preferred stock financing. Sapience issued shares of its convertible preferred stock in this financing. The net proceeds from the preferred stock f

AllMed Healthcare Management, Inc., a leading provider of utilization management (UM) and independent review (IRO) services, today announced that Jeff Keating has joined its executive leadership team as Chief Technology Officer (CTO).

AccuReg, a healthcare technology solutions company offering a full suite of front-end revenue cycle management solutions for health systems and hospitals, has acquired Orlando-based Zenig, an innovator in patient engagement technology solutions that enable touchless check-in, virtual waiting rooms, patient flow and bi-directional communication methods.